Claim · model-written summary
The combination of Beauveria bassiana and salicylic acid gave the highest Lobesia botrana larval mortality, 87.5% at 28 °C.
- Taxon
- L. botrana
Lobesia botranae1 - Treatment
- Combination EPF and SA treatmentse1
- Interactor
- L. botrana
Lobesia botranae1pest - Second interactor
- B. bassiana
Beauveria bassianae1biocontrol_agent - Outcome
- larval mortalitye1
- Direction
- higheste1
- Value
- 87.5%e1
- Qualifier
- 28 °Ce1
Not reportedComparator
Verbatim
e1“Combination EPF and SA treatments presented the highest larval mortality of L. botrana (87.5% at 28 °C and 77.5% at 24 °C for B. bassiana and I. fumosorosea, respectively)”
Title
Evangelos Beris; Xenophon Venios; Dimitrios Papachristos; et al. Microorganisms 2025. doi:10.3390/microorganisms13071630
Other claims from this paper (9)
- Intervention effect Foliar application of entomopathogenic fungi increased the electron transport rate from PSII to PSI in grapevine compared with control plants.
- Intervention effect Entomopathogenic fungi elevated the transpiration rate and stomatal conductance of grapevine.
- Intervention effect Salicylic acid treatments decreased transpiration rate and stomatal conductance of grapevine.
- Intervention effect The high salicylic acid dose (10 mM) reduced the Fv/Fm value in grapevine, accompanied by phytotoxic spots on leaves.
- Intervention effect Spore germination of Beauveria bassiana and Isaria fumosorosea was significantly reduced only by the salicylic acid concentration of 2 mM.
- Intervention effect Salicylic acid at 0.5 and 1 mM did not affect spore germination of Beauveria bassiana and Isaria fumosorosea.
- Intervention effect The combination of Isaria fumosorosea and salicylic acid gave the highest Lobesia botrana larval mortality, 77.5% at 24 °C.
- Intervention effect Salicylic acid reduced larval mycosis of Lobesia botrana in most cases.
- Recommendation The authors suggest that entomopathogenic fungi and salicylic acid can be co-applied in vineyard integrated strategies to support grapevine health.